Type 1 diabetes incidence was 1.14 times higher in the first year and 1.27 times higher in the second year of the COVID-19 pandemic, compared with the 12 months before the pandemic.
The American Diabetes Association (ADA) announced updates to multiple sections of its Standards of Care in Diabetes–2023, as announced at the ADA 83rd Scientific Sessions.
Improving access to diabetes technology so that everyone can benefit is a top priority, said David Maahs, MD, PhD, professor of pediatrics at Stanford University and division chief of pediatric endocrinology at Lucile Packard Children’s Hospital.